Detalhe da pesquisa
1.
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
N Engl J Med
; 389(15): 1390-1401, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754204
2.
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Invest New Drugs
; 41(2): 267-275, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792805
3.
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Clin Infect Dis
; 73(7): e1507-e1517, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897367
4.
Ceftobiprole for Staphylococcus aureus Bacteremia. Reply.
N Engl J Med
; 389(26): 2498-2499, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157515
5.
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
Br J Cancer
; 123(9): 1360-1369, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741975
6.
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1067-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471863
7.
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Clin Infect Dis
; 68(12): 1981-1989, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289478
8.
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Clin Infect Dis
; 69(11): 1912-1918, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722013
9.
Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases.
J Antimicrob Chemother
; 74(3): 761-767, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476108
10.
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
BMC Infect Dis
; 19(1): 195, 2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808293
11.
Mucormycosis in South America: A review of 143 reported cases.
Mycoses
; 62(9): 730-738, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192488
12.
Detection of circulating tumour cell clusters in human glioblastoma.
Br J Cancer
; 119(4): 487-491, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30065256
13.
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
J Antimicrob Chemother
; 73(3): 757-763, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29194488
14.
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Mycoses
; 61(7): 420-429, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570857
15.
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Mycoses
; 61(11): 868-876, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035825
16.
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28289034
17.
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.
Transpl Infect Dis
; 19(5)2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28722255
18.
Mechanisms of hepatotoxicity associated with the monocyclic ß-lactam antibiotic BAL30072.
Arch Toxicol
; 91(11): 3647-3662, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536862
19.
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
Clin Infect Dis
; 63(3): 356-62, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27169478
20.
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
Clin Infect Dis
; 59(1): 51-61, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723282